These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Cancer; 2007 Feb 15; 109(4):668-74. PubMed ID: 17211862 [Abstract] [Full Text] [Related]
4. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ. Am J Gastroenterol; 2009 Nov 15; 104(11):2673-80. PubMed ID: 19638963 [Abstract] [Full Text] [Related]
5. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Am J Gastroenterol; 2000 Feb 15; 95(2):387-94. PubMed ID: 10685740 [Abstract] [Full Text] [Related]
6. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus. Weston AP, Badr AS, Hassanein RS. Am J Gastroenterol; 1999 Dec 15; 94(12):3420-6. PubMed ID: 10606297 [Abstract] [Full Text] [Related]
14. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL. Am J Gastroenterol; 2005 Apr 15; 100(4):775-83. PubMed ID: 15784018 [Abstract] [Full Text] [Related]
15. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Am J Gastroenterol; 2002 Aug 15; 97(8):1930-6. PubMed ID: 12190156 [Abstract] [Full Text] [Related]
16. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z, Mickevicius A, Kiudelis M. Zentralbl Chir; 2004 Apr 15; 129(2):99-103. PubMed ID: 15106039 [Abstract] [Full Text] [Related]
17. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD. Am J Gastroenterol; 2011 Jul 15; 106(7):1231-8. PubMed ID: 21577245 [Abstract] [Full Text] [Related]
19. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M. J Gastroenterol Hepatol; 2008 Sep 15; 23(9):1362-7. PubMed ID: 18205769 [Abstract] [Full Text] [Related]
20. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. Am J Gastroenterol; 1998 Apr 15; 93(4):536-41. PubMed ID: 9576444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]